ArticleFrontiers in oncology2025
Imaging features of CT and MR in hepatic perivascular epithelioid cell tumor: case series and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Primary Hepatic Perivascular Epithelioid Cell Tumors: From Diagnosis to Treatment.Life (Basel, Switzerland) · 2026Review
- Laparoscopic partial hepatectomy for primary hepatic PEComa: a case report.BMC gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To retrospectively analyze the clinical and imaging data of 4 patients with hepatic PEComa of different pathological grades, and to review relevant literature, aiming to enhance clinical awareness of this disease and provide support for preoperative diagnosis. Methods: A retrospective analysis was conducted on 4 cases of patients with hepatic PEComa who were confirmed by surgery and biopsy in our hospital. All patients had complete clinical data, including laboratory tests, abdominal imaging studies, as well as pathological and immunohistochemical examinations. Results: Four cases of hepatic PEComa were identified. All patients were female, aged between 51 and 62 years. The largest diameter of the lesions ranged from 2.4 cm to 20.0 cm. All four lesions presented a round or oval shape with well-defined margins. Three lesions showed homogeneous density/signal, while one lesion displayed heterogeneous density with extensive necrosis. All four cases had a rich blood supply, characterized by significant enhancement in the arterial phase. In two cases, curved and dilated feeding arteries were observed at the periphery of the lesions, and in one case, early visualization of the hepatic vein occurred during the arterial phase. Immunohistochemical staining was positive for HMB45 (+/++), Melan-A (+/++), and SMA (+/++) in all four cases. Conclusion: Hepatic PEComa is a rare tumor with no typical clinical manifestations, and laboratory tests usually show no significant abnormalities. CT and MRI are valuable in preoperative diagnosis. When a lesion exhibits prominent arterial phase enhancement along with thickened and tortuous vessels, and there are no specific findings in the clinical history and laboratory tests, hepatic PEComa should be included in the differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.